Curakne 5 mg, Weichkapseln

7680568850106 CH-56885 Weichkapseln

Associated product:

CURAKNE caps moll 5 mg 30 pce
Curakne 5 mg, Weichkapseln
Curakne 5 mg, Weichkapseln
Curakne 5 mg, Weichkapseln
1 / 3
google

Article details

Package size
30
Selling units
30
Measure
Kapsel(n)
Galenic form
Weichkapseln
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/06/2025
Patient information leaflet
Français
05/06/2025
Patient information leaflet
Italien
05/06/2025
Summary of Product Characteristics
Allemand
05/06/2025
Summary of Product Characteristics
Français
05/06/2025
Summary of Product Characteristics
Italien
05/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
sojae oleum
52.1 MG Substance HBESI
cera flava
- Substance HNIDK
oleum vegetabile hydrogenatum
- Substance HNIDK
gelatina
- Substance HNIDK
glycerolum
- Substance HNIDK
aqua purificata
- Substance HNIDK
lecithinum
- Substance HNIDK
triglycerida media
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (rubrum)
- Substance FTODK
E 172 (flavum)
- Substance FTODK
ethanolum
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
E 172 (nigrum)
- Substance FTODK
polyvinylis acetas phtalas
- Substance HNIDK
aqua purificata
- Substance HNIDK
alcohol isopropylicus
- Substance HNIDK
macrogolum 400
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammonii hydroxidum
- Substance HNIDK

Reimbursement information

Public price
CHF 16.35
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/09/2006

Authorization holder

Pierre Fabre Pharma SA

4052 Basel

Authorization information

Swissmedic authorization number
56885
Drug name
Curakne, Weichkapseln
Galenic form
KAPWE
ATC Code
D10BA01
Authorization status
Z
Dispensing category
A
First authorization
05/10/2004
Authorization expiration date
31/12/9999
IT Number
10.02.0.
Domain
Human medicine
Field of application
Schwere therapieresistente Formen von Akne

Package details

Description (FR)
CURAKNE caps moll 5 mg 30 pce
Description (DE)
CURAKNE Weichkaps 5 mg 30 Stk
Market launch
07/04/2006
Narcotic (BTM)
No

Other package sizes (6)

CURAKNE caps moll 10 mg 30 pce
30 KAP
GTIN: 7680568850021
View
CURAKNE caps moll 10 mg 100 pce
100 KAP
GTIN: 7680568850045
View
CURAKNE caps moll 20 mg 30 pce
30 KAP
GTIN: 7680568850069
View
CURAKNE caps moll 20 mg 100 pce
100 KAP
GTIN: 7680568850083
View
CURAKNE caps moll 5 mg 100 pce
100 KAP
GTIN: 7680568850120
View
CURAKNE caps moll 40 mg 30 pce
30 KAP
GTIN: 7680568850137
View